Please select the option that best describes you:

What is your approach to VTE prophylaxis in hospitalized patients who are already on DAPT?  

Particularly with prolonged hospitalizations, do you have any concerns about exposing patients to bleeding risks associated with "triple therapy" even though dosing for the anticoagulant is prophylactic?